About
Professional record
I know both sides of the table: sponsor economics and local execution.
Both sides of the table
As a Clinical Lead at a Philippine CRO, I manage studies from feasibility through closeout. At BPIQ & BiopharmIQ, a U.S.-based biopharma intelligence company, I analyse clinical catalysts, regulatory milestones, financings, and M&A.
That combination is the point. Sponsor strategy set without local execution reality produces timelines nobody can hit; local execution without sponsor economics produces a partner who cannot read your board deck.
- Study operations
- Phase I–IV and non-interventional, feasibility through closeout
- Quality systems
- ICH-GCP-aligned SOPs and quality management
- Regulatory
- Submissions, site management, sponsor communications
- Market intelligence
- Clinical catalysts, competitive and M&A analysis
Disclosure
How I am paid, stated plainly
There is no fee to you at any stage. I am compensated by the partner CRO once you sign — which means you should know my incentive before you weigh my advice, not after.
Two commitments follow from that: I will tell you when the Philippines is the wrong answer for your protocol, and I will disclose the commercial terms of any partner I put in front of you, on request.
Leadership & academic impact
Mentorship, teaching, and the work of building a research community.